CSI Market
Sign In | Register

Century Therapeutics inc (IPSC) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access IPSC quarterly Cash Flow →
Cash flow performance over multiple periods helps investors evaluate the stability of Century Therapeutics inc's cash-generating activities.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-9.58
Depreciation & amortization13.10
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue-109.16
Asset Impairment Charges6.76
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation6.84
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Write Off Of In Process Research And Development Asset-
Non Cash Operating Lease Expense1.91
Increase Decrease In Escrow Deposit-
Business Combination Contingent Consideration Arrangements Gain In Amount Of Contingent Consideration Liability-4.53
Increase Decrease In Operating Lease Liability-4.98
Income taxes-0.07
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable1.56
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-4.32
Increase (Decrease) in Security Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets2.34
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-3.75
Discontinued operations0.00
Net Cash flow from Operating Activities-103.88
Investing Activities
Capital Expenditures-0.85
Sale of Capital Items0.00
Proceeds from Sale of Available-for-sale Securities, Debt159.52
Payments to Acquire Available-for-sale Securities, Debt-51.17
Real Estate Investments0.00
Payments To Acquire Assets Net Of Cash Acquired-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Payments to Acquire Additional Interest in Subsidiaries0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities107.50
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.17
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Subscription Receivable-
Cash Contributed Resulting From Merger-
Proceeds From Issuance Of Long Term Debt And Warrants Net-
Proceeds From At Market Net Of Issuance Costs-
Proceeds From Pipe Net Of Issuance Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.17
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-104.72
Total Cash Flow3.80
4 historic quarters locked

Sign in to unlock the full Century Therapeutics inc cash flow history.

Sign In Create Free Account

About Century Therapeutics Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-26-026759

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License